BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 29
• 30
• 31

• Pharm Country

  BioSpecifics Technologies Corporation to Host Conference Call to Report First Quarter 2012 Financial Results on May 8, 2012

  May 1, 2012

   · 

  2 min read
• Drug Development

  Varian Medical Systems Release: Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way

  May 1, 2012

   · 

  4 min read
• Deals

  US Based Ventus Medical Announces IPO and Plans to List on the Australian Securities Exchange

  May 1, 2012

   · 

  5 min read
• Business

  Acella Pharmaceuticals, LLC Announces a New Addition to the Commercial Team

  May 1, 2012

   · 

  1 min read
• Deals

  Johnson & Johnson New CEO’s Takeover Watch Spans Edwards Lifesciences’S to St. Jude Medical: Real M&A

  May 1, 2012

   · 

  1 min read
• FDA

  ProPep Surgical Receives CE Mark for its ProPep Nerve Monitoring System™

  May 1, 2012

   · 

  2 min read
• Pharm Country

  Lixte Biotechnology Announces Submission of an IND to the FDA for Approval of a Clinical Trial of LB-100, a First-in-Class, Anti-Cancer Compound

  May 1, 2012

   · 

  3 min read
• FDA

  Vessix Vascular, Inc. Receives CE Mark for V2 Renal Denervation System™ for Treatment of Hypertension

  May 1, 2012

   · 

  4 min read
• BioMidwest

  Vitro Biopharma Responds to Recent Market Activity

  May 1, 2012

   · 

  1 min read
• Business

  Verona Pharma Appoints New CEO

  May 1, 2012

   · 

  2 min read